Eurobio Scientific Logo

Eurobio Scientific

Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.

ALERS | PA

Overview

Corporate Details

ISIN(s):
FR0004054435 (+2 more)
LEI:
969500IQEUEH806GE257
Country:
France
Address:
7 AVENUE DE SCANDINAVIE, 91940 LES ULIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eurobio Scientific is an integrated specialty diagnostics company focused on developing, manufacturing, and distributing in-vitro diagnostic (IVD) tests and life sciences products for clinical use. The company's core areas of expertise are transplantation, infectious diseases, and oncology. Its portfolio includes a range of molecular diagnostics technologies, such as prognostic genomic tests for cancer, reagents and software for transplant matching, and genetic tests for various illnesses. Eurobio Scientific serves laboratories and healthcare providers, offering both its own proprietary solutions, which constitute a significant portion of its revenue, and products from partner companies through its distribution network.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-13 18:30
Interim / Quarterly Report
EUROBIO SCIENTIFIC : RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2025
French 947.6 KB
2025-09-24 17:40
Earnings Release
Eurobio Scientific : résultat du 1er semestre 2025
French 270.5 KB
2025-09-24 17:40
Earnings Release
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
English 276.5 KB
2025-07-01 17:45
M&A Activity
Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Vod…
French 177.0 KB
2025-07-01 17:45
M&A Activity
Eurobio Scientific completes the acquisition of Life Science unit of Voden Med…
English 173.7 KB
2025-06-17 16:59
Major Shareholding Notification
Franchissement de seuils
French 116.1 KB
2025-05-19 19:16
Major Shareholding Notification
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
French 135.1 KB
2025-05-19 19:16
Major Shareholding Notification
Eurobio Scientific: EB Development rises above 90% threshold
English 134.8 KB
2025-04-29 21:00
Report Publication Announcement
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
French 610.9 KB
2025-04-28 17:46
Earnings Release
Eurobio Scientific : RESULTAT ANNUEL 2024 - Croissance du cœur d’activité et dé…
French 216.3 KB
2025-04-28 17:46
Earnings Release
Eurobio Scientific: 2024 annual results
English 231.2 KB
2025-03-12 17:35
M&A Activity
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE
French 131.2 KB
2025-03-12 17:35
M&A Activity
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
English 133.7 KB
2025-03-04 20:03
Regulatory Filings
Eurobio Scientific : résiliation du contrat de liquidité
French 134.6 KB
2025-01-15 17:46
Report Publication Announcement
Eurobio Scientific : calendrier des publications financieres 2025
French 598.6 KB

Automate Your Workflow. Get a real-time feed of all Eurobio Scientific filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eurobio Scientific

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eurobio Scientific via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-12-18 N/A Other Buy 1,000 15,180.00 EUR

Peer Companies

Lipidor AB Logo
Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.
Sweden
LIPI
Lipocine Inc. Logo
Biopharma developing oral drugs for metabolic & endocrine disorders using delivery technology.
United States of America
LPCN
Liquidia Corp Logo
Develops inhaled therapies for rare cardiopulmonary diseases using proprietary PRINT® technology.
United States of America
LQDA
LISATA THERAPEUTICS, INC. Logo
Oncology firm with a platform for more effective, targeted delivery of anti-cancer drugs.
United States of America
LSTA
Longeveron Inc. Logo
Develops cell therapies for Alzheimer's, aging frailty, and rare infant heart defects.
United States of America
LGVN
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland
LONN
Lyell Immunopharma, Inc. Logo
Develops durable CAR T-cell therapies for solid tumors & blood cancers by reprogramming T-cells.
United States of America
LYEL
Lyra Therapeutics, Inc. Logo
Developing localized, long-acting therapies for chronic rhinosinusitis (CRS).
United States of America
LYRA
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway
LYTIX
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland
MAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.